|Articles|June 1, 2003

June 2003 - Special Issue
Volume 9
Issue 1 SP

Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Author(s)Joel W. Hay, PhD

Download PDF: Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Articles in this issue

about 23 years ago

Article

New Evidence to Explain Rising Healthcare Costs

about 23 years ago

Article

Understanding the Underlying Drivers of Inpatient Cost Growth: A Literature Review

about 23 years ago

Article

Drivers of Expenditure Growth in Outpatient Care Services

about 23 years ago

Article

Drivers of Healthcare Expenditures Associated With Physician Services

about 23 years ago

Article

Exploring the Relationship Between Inpatient Hospital Costs and Quality of Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer

FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs

MS Likely Unfolds Along a Continuum Years Before First Symptoms

Innovation Is Outpacing Reimbursement, Health System Execs Warn